Our history is a testament that science is in our DNA
Driven by an unparalleled commitment to improving human health by pioneering translational genetics/genomics research and accelerating the development of advanced technologies in precision medicine today.
2003
Leader
in genetics with genome-wide analysis study (GWAS) design
2003
Early Adopter
of Affymetrix microarray technology for single nucleotide and copy number polymorphisms (SNP, CNP)
2008
Early Adopter
of Affymetrix DMET™ microarray technology for pharmacogenomics-based personalized medicine
2009
Established
advanced genomics diagnostic laboratory (CAP accredited) in joint venture between Medical College of WI and Children’s Hospital of WI specializing in cytogenetic/copy number analysis microarrays
2010
Established
running DMET™ micoarrays clinically in second CLIA accredited diagnostic laboratory at Medical College of WI
2010
Early Adopter
of Next Generation Sequencing (NGS)
2012-2017
Published
20+ PGx- and NGS-peer reviewed journal articles
2017
Established
RPRD Diagnostics, LLC – first patient result reported on April 13th
2017
First to Offer
Whole Pharmacogenomics Scan (WPS™) clinically
2018
First to Offer
CEP72, NUDT15, and TPMT (CNT) Panel clinically
2018 and beyond
PGx Community Leader
with continued PGx publications, consortium memberships, and conference presentations
